DJIA 18,041.54 -190.48 -1.04%
NASDAQ 5,032.75 -56.61 -1.11%
S&P 500 2,104.20 -21.86 -1.03%
market minute promo

Delcath Systems, Inc. (NASDAQ: DCTH)

0.85 -0.03 (-3.66%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

DCTH $0.85 -3.66%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.89
Previous Close $0.88
Daily Range $0.85 - $0.95
52-Week Range $0.80 - $3.00
Market Cap $10.4M
P/E Ratio -0.56
Dividend (Yield) $0.00 (0.0%)
Volume 108,303
Average Daily Volume 91,526
Current FY EPS $0.00

Sector

Healthcare

Industry

Drug Makers

Delcath Systems, Inc. (DCTH) Description

The Company is a development stage Company. Website: http://www.delcath.com/

News & Commentary

Why Did My Stock Just Die?

These stocks just rolled over. Which ones will bounce back?

Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest EPS Growth Forecast For Next 5 Ye

Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest EPS Growth Forecast For Next 5 Years

ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open F

ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment

Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic

Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma

3 Basic Checks To Value Cheap Net Net Stocks

Delcath Adds New U.S. Center To Global Phase 2 Hepatocellular Carcinoma Program

Delcath to Offer Data Highlighting Melphalan/HDS Trial at SSO Annual Meeting

Top Performing Industries For February 19, 2015

Stocks Hitting 52-Week Lows

Morning Market Losers

Earnings Preview: Intuitive Surgical Q4 2014

See More DCTH News...

DCTH's Top Competitors

DCTH $0.85 (-3.66%)
Current stock: DCTH
$0.00 (0.00%)
Current stock:
MDT $76.57 (-1.61%)
Current stock: MDT
COV $0.00 (0.00%)
Current stock: COV